---
title: "Oruka Therapeutics SVP Finance Arjun Agarwal sells USD 840,975 in common shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292532295.md"
description: "Oruka Therapeutics SVP of Finance Arjun Agarwal sold 10,299 common shares on July 13, 2026, at prices between $83.07 and $85.63, totaling approximately USD 840,975. He also exercised employee stock options for 9,999 shares. Following these transactions, his direct common stock stake was reduced to 15,312 shares."
datetime: "2026-07-13T21:10:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292532295.md)
  - [en](https://longbridge.com/en/news/292532295.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292532295.md)
generator: "portal-rs"
---

# Oruka Therapeutics SVP Finance Arjun Agarwal sells USD 840,975 in common shares

-   Oruka Therapeutics SVP of Finance Arjun Agarwal cut his direct common stock stake to 15,312 shares on July 13, 2026. \* Disposed of 10,299 shares in open-market sales at weighted average prices between $83.07 and $85.63. \* Exercised employee stock options for 9,999 shares at $12.5 and $34.39. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oruka Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000907654-26-000071), on July 13, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [ORKA.US](https://longbridge.com/en/quote/ORKA.US.md)

## Related News & Research

- [278,164 Shares in Oruka Therapeutics, Inc. $ORKA Acquired by Braidwell LP](https://longbridge.com/en/news/297882643.md)
- [Oruka Therapeutics reports Q2 2026 results: $1.1B cash; net loss $41.2M in quarter](https://longbridge.com/en/news/295396150.md)
- [Outlook Therapeutics CFO Kevin Michael Lundquist files initial beneficial ownership statement](https://longbridge.com/en/news/297827378.md)
- [ProQR Therapeutics held annual shareholder meeting in Amsterdam](https://longbridge.com/en/news/297613300.md)
- [Abeona Therapeutics director Mark Alvino disposes of 15,000 common shares worth $87,966](https://longbridge.com/en/news/297702333.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**